The 100 Most Influential CEOs in Oncology in 2025 (Full List)
"Peace is the Best Medicine" - WHO Director-General Announces What Healthcare is Missing
TWINPEAK study: Spevatamig Plus Gemcitabine and Nab-Paclitaxel as 1L Therapy in CLDN18.2 Positive mPDAC
Dual Checkpoint Blockade in Refractory Anal Squamous Cell Carcinoma
Adham Jurdi Has Been Appointed Sr Medical Director of GI Oncology and Innovations at Natera
CRITICS-II Trial at ASCO GI: Total Neoadjuvant Therapy in Resectable Gastric Cancer
CheckMate 9DW at ASCO GI 2026: Nivolumab plus ipilimumab vs lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma
Highlights from ASCO GI 2026 by Wafik El-Deiry
The 2026 NCODA Global Oncology and Hematology Congress is a premier international gathering of oncology, hematology, and technology experts scheduled for March 11–12, 2026, in Dublin, Ireland. Organized by NCODA, […]
